Drugs / nL-MAPK8-001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07197294 | Feb 2025 → Feb 2027 expected | neurodevelopmental disorder with or without variable brain abnormalities; NEDBA | n-Lorem Foundation | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | nL-MAPK8-001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07197294 ↗ |